ARTSS-2: A pilot, phase IIb, randomised, multi-center trial of Argatroban in combination with recombinant tissue plasminogen activator for acute stroke
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Argatroban (Primary) ; Alteplase
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms ARTSS-2
- 21 Apr 2016 Results presented at the 68th Annual Meeting of the American Academy of Neurology
- 19 Feb 2016 Status changed from active, no longer recruiting to discontinued as reported by results presented at the 41st International Stroke Conference
- 19 Feb 2016 Results presented at the 41st International Stroke Conference